Oklahoma City Taxotere Lawyers
Fighting Large Corporations on Your Behalf
Taxotere® (docetaxel) is a chemotherapy drug that is approved for the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer, and metastatic prostate cancer. It is administered intravenously through a vein and is member of a family of drugs called taxanes. It is used to try to prevent cancer cells from growing and dividing. Taxotere is normally used in combination with other drugs such as capecitabine, cisplatin, fluorouracil, doxorubicin, and cyclophosphamide to fight off cancer and provide patients with better survival rates. It acts as an anti-mitotic agent, meaning that it disrupts cellular division. It is usually administered intravenously during hour-long infusion cycles that are repeated every three to four weeks.
Most chemotherapy drugs are known to cause temporary hair loss, with hair growing back soon after treatment ends. Unfortunately, that has not been the case with Taxotere users diagnosed with alopecia universalis, a condition characterized by a loss of all body hair, which may never return. Another serious potential side effect of Taxotere is neutropenic enterocolitis, which is the inflammation of a small pouch located at the head of the large intestine. Although the condition is rare, it can be fatal.
Additional common side effects of using Taxotere include:
- Bone, muscle, or joint pain
- Fatigue and weakness
- Fluid retention with weight gain, including swelling of the ankles or abdominal area
- Nail changes (color changes to fingernails or toenails)
- Low red blood cell count (anemia)
- Mouth or throat sores
- Peripheral neuropathy (numbness in fingers and toes)
- Taste changes
Claims are being filed against the manufacture, Sanofi-Aventis, by women who have suffered permanent hair loss as a result of being prescribed Taxotere. Attorneys state that if the manufacturer had properly warned of the risks, patients would have been prescribed a different chemotherapy drug called Taxol, which is more effective than Taxotere and does not result in permanent hair loss.
Further allegations include:
- Taxotere is defective and unreasonably dangerous
- Sanofi-Aventis was negligent in the manufacturing of Taxotere
- Sanofi-Aventis failed to properly test Taxotere and failed to warn doctors and patients of the potential for alopecia
- Sanofi-Aventis concealed evidence of the dangers of Taxotere and misrepresented the effectiveness and safety of it in its marketing material
If you or a loved one have been affected by the drug Taxotere, we encourage you to consult with our team as soon as possible. With our extensive knowledge and expertise, you can rest assured that you will have legal representation you can trust. All initial consultations are free, and we don’t charge any up-front fees for representation. We handle all fees on a contingency basis, meaning that unless we’re successful, you don’t have to pay us.
You can rely on our tenacious and hardworking team to fight tirelessly for every penny you are owed.